R&D News | pharmaphorum

News

Report suggests UK's national vaccine facility is on the blo...

The UK’s Vaccines Manufacturing and Innovation Centre (VMIC) – unveiled with fanfare by the government in 2018 – is rumoured to be up for sale.

News

Pharma pledges rapid response to Omicron COVID variant

With governments around the world announcing measures to curb the new B.1.1.529 variant of COVID-19 – now christened Omicron – leading vaccine manufacturers have said they are poised to dev

News

The critical role of the generics sector during the pandemic

Could safety scupper Ionis, Pfizer's cholesterol drug vupano...

Ionis has reported phase 2b trial data for its Pfizer-partnered antisense drug vupanorsen for cholesterol lowering that showed it met its main efficacy targets, but raised a few safety conc

News

Fall in efficacy of Merck's molnupiravir puts Pfizer in driv...

Merck & Co has reported new data with its oral antiviral molnupiravir that suggests it is not as effective against COVID-19 as originally hoped.

News

Concept of memory loss and brain aging due to dementia and alzheimer's disease as a medical icon with fall trees shaped as a human head losing leaves with 3D illustration elements.

Trial of intranasal Alzheimer's vaccine gets underway in US

The first patients are now being treated as part of a first-in-human trial of a vaccine, administered as a nasal spray, that aims to slow down the progression of Alzheimer's disease (AD).

News

Chinese tech giant Baidu licenses mRNA algorithm to Sanofi

Sanofi has bolstered its push into mRNA-based therapies with a new licensing deal – but not as might be expected with some up-and-coming biotech company.

Report suggests UK's national vaccine facility is on the blo...

Pharma pledges rapid response to Omicron COVID variant

Could safety scupper Ionis, Pfizer's cholesterol drug vupano...

Fall in efficacy of Merck's molnupiravir puts Pfizer in driv...

Trial of intranasal Alzheimer's vaccine gets underway in US

Chinese tech giant Baidu licenses mRNA algorithm to Sanofi

Five indications added to Pharmacy First prescribing scheme

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks